Megakaryocyte-mediated inhibition of osteoclast development

被引:72
作者
Kacena, Melissa A.
Nelson, Tracy
Clough, Mary E.
Lee, Sun-Kyeong
Lorenzo, Joseph A.
Gundberg, Caren M.
Horowitz, Mark C.
机构
[1] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06520 USA
[2] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA
关键词
megakaryocyte; osteoclast inhibition; OPG; cytokine;
D O I
10.1016/j.bone.2006.05.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A growing body of evidence indicates that megakaryocytes (MK) or their growth factors play a role in skeletal homeostasis. We previously identified a novel regulatory pathway that controls bone formation, which is mediated by MK. In vivo megakaryocytosis resulted in massive bone formation. The co-culture of MK with osteoblasts (OB) resulted in increased OB proliferation in vitro, by a mechanism that required direct cell-to-cell contact. Here, we examined a second MK-mediated pathway that regulates osteoclast (OC) development. We have begun examining the unique inhibitory effect of MK on OC development. Spleen or bone marrow (BM) cells from C57BL/6 mice, as a source of OC precursors, were cultured with M-CSF and RANKL to induce OC development. MK were prepared by culturing fetal liver cells with thrombopoietin and separating cells into MK and non-MK populations. MK were titrated into spleen cell cultures and OC were identified as tartrate-resistant acid phosphatase-positive giant cells with > 3 nuclei. There was a significant, P < 0.001, up to 10-fold reduction in OC formed when MK were added to the spleen cell cultures. We determined that 30% (vol:vol) MK conditioned media (CM) were able to completely block OC development from precursors, whereas 3% MK CM resulted in up to a 10-fold reduction in OC development, P < 0.001. These data indicate that a soluble factor(s) was responsible, at least in part, for the inhibition. We examined MK CM for known inhibitors of OC formation, using ELISAs. IL-4,,vas undetectable in MK CM, whereas IL-10 and IFN-gamma levels were similar in MK and non-MK CM. TGF beta-1 levels were increased 2-fold in MK CM compared to control CM but were not responsible for the inhibition in OC development. Although, we found a significant increase in the levels of osteoprotegerin (OPG) in MK CM, antibody neutralization studies, MK derived from OPG-deficient mice, and tandem mass spectrophotometry, all confirm that OPG was not responsible for the MK-mediated inhibition of OC development. Overall, these data suggest that ail unidentified factor(s) is present in MK CM that inhibits OC development. These studies indicate that MK can play a dual role in skeletal homeostasis by stimulating OB proliferation and simultaneously inhibiting OC development. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 55 条
[11]  
Frey BM, 1998, SCHWEIZ MED WSCHR, V128, P1587
[12]   TGF-β enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF [J].
Galvin, RJS ;
Gatlin, CL ;
Horn, JW ;
Fuson, TR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :233-239
[13]  
HATTERSLEY G, 1991, J BONE MINER RES, V6, P165
[14]   Osteoclastic potential of human CFU-GM: Biphasic effect of GM-CSF [J].
Hodge, JM ;
Kirkland, MA ;
Aitken, CJ ;
Waugh, CM ;
Myers, DE ;
Lopez, CM ;
Adams, BE ;
Nicholson, GC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (02) :190-199
[15]   Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors [J].
Horowitz, MC ;
Xi, YG ;
Pflugh, DL ;
Hesslein, DGT ;
Schatz, DG ;
Lorenzo, JA ;
Bothwell, ALM .
JOURNAL OF IMMUNOLOGY, 2004, 173 (11) :6583-6591
[16]   Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor [J].
Horwood, NJ ;
Udagawa, N ;
Elliott, J ;
Grail, D ;
Okamura, H ;
Kurimoto, M ;
Dunn, AR ;
Martin, TJ ;
Gillespie, MT .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :595-603
[17]   IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro [J].
Horwood, NJ ;
Elliott, J ;
Martin, TJ ;
Gillespie, MT .
JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :4915-4921
[18]   Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts [J].
Hu, YS ;
Zhou, H ;
Myers, D ;
Quinn, JMW ;
Atkins, GJ ;
Ly, C ;
Gange, C ;
Kartsogiannis, V ;
Elliott, J ;
Kostakis, P ;
Zannettino, ACW ;
Cromer, B ;
McKinstry, WJ ;
Findlay, DM ;
Gillespie, MT ;
Ng, KW .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (01) :89-99
[19]   CYTOKINE PRODUCTION BY PRIMARY BONE-MARROW MEGAKARYOCYTES [J].
JIANG, SX ;
LEVINE, JD ;
FU, YG ;
DENG, BJ ;
LONDON, R ;
GROOPMAN, JE ;
AVRAHAM, H .
BLOOD, 1994, 84 (12) :4151-4156
[20]   Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype [J].
Kacena, MA ;
Gundberg, CM ;
Nelson, T ;
Horowitz, MC .
BONE, 2005, 36 (02) :215-223